
Supreme Court Criticizes Hospitals for Charging Rs 1.3 Lakh for Cancer Injection
What Happened?
The Supreme Court has condemned the high prices hospitals charge for medicines, highlighting a case where a cancer injection cost Rs 1.3 lakh instead of Rs 11,000. The court questioned the government's regulatory framework and its effectiveness in controlling drug prices.
Key points
- The Supreme Court criticized hospitals for charging Rs 1.3 lakh for a cancer injection available for Rs 11,000.
- Justices questioned the government's role in allowing such high markups on medicines.
- The court highlighted the difficulty cancer patients face in negotiating prices.
- The Centre's policy on capping trade margins for anti-cancer drugs was also scrutinized.
- Hospitals argued that they rely on revenue from insurance and government health schemes.
Key insights
- The Supreme Court's scrutiny may prompt a review of the existing drug pricing regulations.
- Patients may benefit from increased transparency in drug pricing practices.
- The government's approach to regulating pharmaceutical prices could face significant challenges.
Why it matters
The court's ruling could lead to changes in how hospitals price essential medications, impacting patient care.
Source
India Today

